Immunohistochemical analysis of the activation of NF-κB and expression of associated cytokines and adhesion molecules in human models of allergic inflammation

Journal of Pathology

Volumn 189, Issue 2, 1999, Pages 265-272

  Wilson, Susan J ^c   Leone, Barbara A ^a   Anderson, Donald ^a   Manning, Anthony ^b   Holgate, Stephen T ^d  

^a PFIZER INC   (United States)

^b Signal Pharmaceuticals   (United States)

^c SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^d NONE

Author keywords

Adhesion molecules; Allergic inflammation; Cytokines; Gene regulation; NF B

Indexed keywords

CALPAIN; CELL ADHESION MOLECULE; CYTOKINE; GLIOTOXIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC REACTION; ARTICLE; B LYMPHOCYTE; BRONCHUS; CONTROLLED STUDY; ENDOTHELIUM CELL; EOSINOPHIL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROPHAGE; MAST CELL; NOSE POLYP; PRIORITY JOURNAL; REGULATORY MECHANISM; T LYMPHOCYTE; UMBILICAL VEIN;

EID: 0032852414     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1096-9896(199910)189:2<265::aid-path415>3.0.co;2-%23     Document Type: Article

References (24)

1. Manning AM, Anderson DC. Transcription factor NF-κB, an emerging regulator of inflammation. Ann Rep Med Chem 1994; 29: 235-244.
2. Collins T. Endothelial nuclear factor-κB and the initiation of the atherosclerotic lesion. Lab Invest 1993; 68: 499-508.
3. Blank V, Kourilsky P, Israel A. Cytoplasmic retention, DNA binding and processing of the NF-κB p50 precursor are controlled by a small region in its C terminus. EMBO J 1991; 10: 4159-4167.
4. Read MA, Whitley MZ, Williams AJ, Collins T. NF-κB and IκB: an inducible regulatory system in endothelial activation. J Exp Med 1994; 179: 503-512.
5. Baeuerle PA, Baltimore D. IκB: a specific inhibitor of the NF-κB transcription factor. Science 1988; 242: 540-546.
6. Finco T, Baldwin A. Regulation of NF-κB: the emerging roles of phosphorylation and proteolysis. Immunity 1995; 3: 263-272.
7. Palombella VJ, Rando OJ, Golberg AL, Maniatis T. The ubiquitin proteasome pathway is required for processing the NF-κBi precursor protein and the activation of NF-κB. Cell 1994; 78: 773-775.
8. Baeuerle PA, Henkel T. Function and activation of NF-κB in the immune system. Annu Rev Immunol 1994; 12: 141-179.
9. Jany B, Betz R, Schreck R. Activation of the transcription factor NF-κB in human tracheobronchial epithelial cells by inflammatory stimuli. Eur Respir J 1995; 8: 387-391.
10. Kingston RE. DNA-protein interactions. In: Ausbel FM, Brent R, Kingston RE, et al., eds. Current Protocols in Molecular Biology. New York: Greene and Wiley and Sons, 1993; 12.01-12.10.14.
11. Bennet BL, Lacson RG, Chen CC, et al. Identification of signal-induced IκB-a kinases in human endothelial cells. J Biol Chem 1996; 271: 19680-19688.
12. Galfé G, Milstein G, Wright B. Rat x hybrid myelomas and a monoclonal anti-Fd portion of mouse IgG. Nature 1979; 277: 131-133.
13. Lin YC, Brown K, Siebenlist U. Activation of NF-κB requires proteolysis of the inhibitor IκBa; signal induced phosphorylation of IκBa alone does not release active NF-κB. PNAS 1995; 92: 552-556.
14. Pahl HL, Krauss B, Schulzeosthoff K, et al. The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-κB. J Exp Med 1996; 183: 1829-1840.
15. Bradding P, Mediwake R, Feather IH, et al. TNFa is localised to human mast cells and is released in acute allergic rhinitis. Clin Exp Allergy 1995; 25: 406-415.
16. Broide DH, Lotz M, Cuomo AJ, Coburn DA, Federman EL, Wasserman SI. Cytokines in symptomatic asthmatic airways. J Allergy Clin Immunol 1992; 89: 958-967.
17. Rothlein R, Dustin ML, Marlin SD, Springer TA. A human ICAM-1 distinct from LFA-1. J Immunol 1996; 137: 1270-1274.
18. Britten KM, Howarth PH, Roche WR. Immunohistochemisry on resin sections: a comparison of resin embedding techniques for small mucosal biopsies. Biotech Histochem 1993; 68: 271-280.
19. Kaltschmidt C, Kaltschmidt B, Henkel T, Stockinger H, Baeuerle PA. Selective recognition of the activated form of transcription factor NF-κB by a monoclonal antibody. Biol Chem Hoppe-Seyler 1995; 376: 9-16.
20. Montefort S, Gratziou C, Goulding D, et al. Bronchial biospy evidence for leucocyte infiltration and upregulation of leucocyte-endothelial cell adhesion molecules 6 hours after local allergen challenge of sensitised asthmatic airways. J Clin Invest 1994; 93: 1411-1421.
21. Casale TB, Costa JJ, Galli SJ. TNFa is important in human lung allergic reactions. Am J Respir Cell Mol Biol 1996; 15: 34-44.
22. Redington AE, Howarth PH. Mast cells, cytokines and asthma. Can Respir J 1994; 1: 118-127.
23. Hirata N, Kohrogi H, Iwagoe H, et al. Allergen exposure induces the expression of endothelial adhesion molecules in the passively sensitised human bronchus: time course and the role of cytokines. Am J Respir Mol Cell Biol 1997; 18: 12-10.
24. Djukanovic R. Nasal polyps - a model of chronic respiratory mucosal inflammation. Clin Exp Allergy 1995; 25: 582-585.